ID

13309

Descripción

Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00724386

Link

https://clinicaltrials.gov/show/NCT00724386

Palabras clave

  1. 2/2/16 2/2/16 -
Subido en

2 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00724386

Eligibility Breast Cancer NCT00724386

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed adenocarcinoma of the male or female breast (male or female) with gross, uncontrolled, unresectable breast and/or chest wall disease including:
Descripción

Breast Cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0858252
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0184774
UMLS CUI [4]
C1332928
1. patients with locally advanced unresectable stage iiia or iiib;
Descripción

Staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2216698
UMLS CUI [2]
C2216699
2. patients with locally recurrent (including locoregional lymph nodes) disease for which curative surgery is not thought possible
Descripción

Locally recurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0861355
UMLS CUI [1,2]
C1511562
3. patients with metastatic disease and uncontrolled locoregional disease are eligible.
Descripción

Staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278488
UMLS CUI [2]
C1707001
prior chemotherapy allowed, except for nitrosoureas and mitomycin chemotherapy or high dose chemotherapy with marrow or stem cell rescue.
Descripción

Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C3540781
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C0002475
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C0332196
UMLS CUI [3,3]
C1328050
prior palliative radiation to sites of metastases allowed (i.e. bone, brain, lung)
Descripción

palliative radiation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3641903
4 weeks since any prior treatments (excluding hormonal therapy). concurrent hormonal therapy is not allowed.
Descripción

Prior/ concurrent Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0877050
aged 18 years or older
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
calgb performance status of 0 - 2
Descripción

calgb performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1518965
life expectance of at least 12 weeks
Descripción

Life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
initial laboratory data:
Descripción

laboratory data

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022885
anc count > 1500/mm3
Descripción

anc count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
platelet count > 100,000/mm3
Descripción

platelet count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
creatine ≤ 2.0 mg/dl
Descripción

creatine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201973
bilirubin ≤ 1.5 mg/dl
Descripción

bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
alt (sgpt) ≤ 3 times the upper limit of normal
Descripción

Liver enzymes

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201836
signed informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior breast or chest wall radiation is not allowed unless the proposed site radiation port does not overlap with prior ports
Descripción

Prior radiation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0458344
subjects must not be pregnant (females able to have children must have negative pregnancy test and agree to use adequate contraception)
Descripción

Gynaecological status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032976
UMLS CUI [3]
C0700589
patients with a documented hypersensitivity to e.coli derived proteins are excluded.
Descripción

Allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0014834
UMLS CUI [1,3]
C1441547
UMLS CUI [1,4]
C0033684
no other serious medical condition such as uncontrolled infection that in the opinion of the investigators places patient at undue risk for study treatment
Descripción

Comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488

Similar models

Eligibility Breast Cancer NCT00724386

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Breast Cancer
Item
histologically or cytologically confirmed adenocarcinoma of the male or female breast (male or female) with gross, uncontrolled, unresectable breast and/or chest wall disease including:
boolean
C0858252 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0184774 (UMLS CUI [3])
C1332928 (UMLS CUI [4])
Staging
Item
1. patients with locally advanced unresectable stage iiia or iiib;
boolean
C2216698 (UMLS CUI [1])
C2216699 (UMLS CUI [2])
Locally recurrent disease
Item
2. patients with locally recurrent (including locoregional lymph nodes) disease for which curative surgery is not thought possible
boolean
C0861355 (UMLS CUI [1,1])
C1511562 (UMLS CUI [1,2])
Staging
Item
3. patients with metastatic disease and uncontrolled locoregional disease are eligible.
boolean
C0278488 (UMLS CUI [1])
C1707001 (UMLS CUI [2])
Chemotherapy
Item
prior chemotherapy allowed, except for nitrosoureas and mitomycin chemotherapy or high dose chemotherapy with marrow or stem cell rescue.
boolean
C0392920 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C3540781 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0002475 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C1328050 (UMLS CUI [3,3])
palliative radiation
Item
prior palliative radiation to sites of metastases allowed (i.e. bone, brain, lung)
boolean
C3641903 (UMLS CUI [1])
Prior/ concurrent Therapy
Item
4 weeks since any prior treatments (excluding hormonal therapy). concurrent hormonal therapy is not allowed.
boolean
C0808070 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0877050 (UMLS CUI [2])
age
Item
aged 18 years or older
boolean
C0001779 (UMLS CUI [1])
calgb performance status
Item
calgb performance status of 0 - 2
boolean
C1518965 (UMLS CUI [1])
Life expectancy
Item
life expectance of at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
laboratory data
Item
initial laboratory data:
boolean
C0022885 (UMLS CUI [1])
anc count
Item
anc count > 1500/mm3
boolean
C0948762 (UMLS CUI [1])
platelet count
Item
platelet count > 100,000/mm3
boolean
C0032181 (UMLS CUI [1])
creatine
Item
creatine ≤ 2.0 mg/dl
boolean
C0201973 (UMLS CUI [1])
bilirubin
Item
bilirubin ≤ 1.5 mg/dl
boolean
C1278039 (UMLS CUI [1])
Liver enzymes
Item
alt (sgpt) ≤ 3 times the upper limit of normal
boolean
C0201836 (UMLS CUI [1])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior radiation
Item
prior breast or chest wall radiation is not allowed unless the proposed site radiation port does not overlap with prior ports
boolean
C0458344 (UMLS CUI [1])
Gynaecological status
Item
subjects must not be pregnant (females able to have children must have negative pregnancy test and agree to use adequate contraception)
boolean
C0032961 (UMLS CUI [1])
C0032976 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
Allergy
Item
patients with a documented hypersensitivity to e.coli derived proteins are excluded.
boolean
C0020517 (UMLS CUI [1,1])
C0014834 (UMLS CUI [1,2])
C1441547 (UMLS CUI [1,3])
C0033684 (UMLS CUI [1,4])
Comorbidity
Item
no other serious medical condition such as uncontrolled infection that in the opinion of the investigators places patient at undue risk for study treatment
boolean
C2348568 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial